Counterpoint Mutual Funds’s Genpact G Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$288K Sell
10,479
-102,542
-91% -$3.37M 0.03% 262
2026
Q1
$4.21M Buy
+113,021
New +$4.66M 0.63% 46
2025
Q2
Sell
-26,547
Closed -$1.34M 363
2025
Q1
$1.34M Buy
+26,547
New +$1.32M 0.19% 45
2023
Q2
Sell
-2,301
Closed -$106K 374
2023
Q1
$106K Sell
2,301
-552
-19% -$25.8K 0.09% 217
2022
Q4
$132K Buy
+2,853
New +$130K 0.14% 173
2021
Q3
Sell
-291
Closed -$13K 192
2021
Q2
$13K Buy
+291
New +$13.2K 0.01% 70

Other funds holding G

Counterpoint Mutual Funds's G Position: Q2 2026 in Review

Counterpoint Mutual Funds reduced its Genpact (G) stake by 91% in Q2 2026, selling an estimated $3.37M and leaving 10,479 shares worth $288K. The position accounts for 0.03% of the portfolio, ranked #262.

Counterpoint Mutual Funds first reported a position in G in Q2 2021 and has held it in 6 quarters since. The position peaked at $4.21M in Q1 2026. 480 funds tracked by Wall St. Rank hold G as of Q2 2026.

  • Counterpoint Mutual Funds held 10,479 shares of Genpact worth $288K as of Q2 2026.
  • Counterpoint Mutual Funds sold 102,542 Genpact shares in Q2 2026, an estimated $3.37M.
  • Genpact made up 0.03% of Counterpoint Mutual Funds's portfolio in Q2 2026, its #262 holding.
  • Counterpoint Mutual Funds first reported a position in Genpact in Q2 2021 and has held it in 6 quarters since.
  • Counterpoint Mutual Funds's Genpact position peaked at $4.21M in Q1 2026.
  • 480 funds tracked by Wall St. Rank held Genpact as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.